One model, not three
Commercial terms, channel fees, rebates, and statutory price effects in a single view, so pricing, contracting, and finance decide from the same numbers.
Pharma & biotech · Medtech · Distributors
Revenue management for life sciences: pricing, contracting, and gross‑to‑net.
We model what a contract does to net price before you sign, then run the rebates, chargebacks, and program pricing after — in the systems you already own.
No software to license. Every transaction in scope reviewed. For pharma and biotech manufacturers, medtech manufacturers, and distributors.
- Before you sign. One model shows what the terms do to net revenue, channel fees, and — for drugs and biologics — statutory prices.
- After you close. We process rebates and chargebacks through payment or dispute and close the period, with accruals tied to your books.
- Inside your stack. Advice, builds, and operations in the platforms you already run.
The difference
A tool tells you something's wrong. We fix it and keep it fixed.
Most help in this market is a calculation boutique, a software license with services attached, or an outsourced team. We model the deal, run the period work, and repair the process in your systems — one team, from first model to period close.
Full coverage
Every claim in scope is checked and either paid or disputed, with the support to back it up.
Nothing new to buy
Your ERP, CRM, spreadsheets, or revenue platform. Nothing to license, nothing to migrate off later.
Why now
The rules changed in 2025–2027. Your processes have to keep up.
- Maximum Fair Price. Negotiated Medicare prices took effect January 1, 2026. Manufacturers now effectuate MFP refunds through the Medicare Transaction Facilitator, and the next drugs are on the way.
- IRA Manufacturer Discount Program. It replaced the Coverage Gap Discount Program in 2025, and discounts for specified and small manufacturers phase in through 2031. Accruals and invoices have to track that phase-in.
- 340B rebate model. HRSA's revised rebate pilot is scheduled for January 1, 2027 and is being challenged in court. If and when it takes effect, claims will need validation before rebates are paid.
About
How we work
We work with three kinds of clients: pharma and biotech manufacturers, medtech manufacturers, and distributors. Inside each, we work with the teams that own pricing, contracting, finance, trade, market access, and revenue operations.
We know the data, the calculations, and the systems, so we can find where money leaks — duplicate discounts, missed eligibility, unpaid chargebacks, weak accruals, broken controls — then fix it and run the process.
Who does the work
Senior practitioners who do pricing, contracting, revenue management, and gross-to-net for pharma manufacturers, medtech manufacturers, and distributors, and who have built the systems behind them. The person who scopes the work is the person who does it. We keep few engagements running at once so that holds.
Pharma & biotech
GTN, contracting, rebates, chargebacks, government pricing, IRA, and 340B integrity.
Medtech
GPO and IDN tiers, rebates, chargebacks, accruals, gross-to-net, and VA FSS.
Distributors
Contract-price loads, chargeback submission and reconciliation, and GPO/IDN eligibility.
Services
What we do
Gross-to-net, pricing & deal modeling
See what a contract, price change, or program does to net revenue and channel economics before you sign. The model uses your real contract terms and data, for drugs, devices, or distributed products.
Rebates, chargebacks & accruals
Chargeback management and rebate processing for managed care, GPO, IDN, and wholesaler programs. Contract-price loads, chargeback validation, EDI 844/849/867 reconciliation, rebate payment, and accruals that tie to the GL. For distributors: chargeback submission and reconciliation and GPO/IDN eligibility, so what you claim matches what manufacturers pay.
Government & program pricing
Medicaid Drug Rebate Program (AMP, Best Price, URA), 340B ceiling price, VA FSS and Federal Ceiling Price, and Medicare Part B ASP: calculations, filing support, restatements, and the audit file behind them.
IRA: MDP & Maximum Fair Price
IRA Manufacturer Discount Program invoices, phase-in tracking, and accruals; Maximum Fair Price effectuation and refund reconciliation.
340B & rebate integrity
Find 340B duplicate discounts and ineligible rebate claims, and build the documentation for good-faith inquiries and disputes.
Systems & workflows
Calculation, accrual, and claims workflows built in the platform you already use — CRM, ERP, spreadsheets, or specialty tools. Any platform.
Government programs (Medicaid, 340B, VA FCP, Part B ASP, and the IRA) apply to drug and biologic manufacturers. Contracting, GPO/IDN rebates, chargebacks, and VA FSS apply across pharma, biotech, medtech, and distribution.
Engagements
Assess · Build · Run
Start with a 2-week, fixed-fee review. Keep us for the build or the period work if it helps.
-
Assess · 2 weeks · fixed fee
Deal-impact & readiness review
A fixed-scope look at how a proposed contract, channel change, or program affects net price and statutory prices, and what in your data or process would block a clean close.
You getA deal-impact model in your format, a written findings memo, and a ranked fix list with owners.
-
Build
Workflows & controls in your stack
We design and implement calculation, accrual, eligibility, or integrity workflows in the tools you already run, then hand them to your team.
You getThe workflow running in your system, a control checklist, a test log against real transactions, and a runbook your team can operate without us.
-
Run · monthly or quarterly
Ongoing rebate, chargeback & integrity ops
Period operations from claim intake through payment or dispute, with accruals reconciled every close.
You getEvery claim validated and either paid or disputed, an accrual roll-forward tied to the GL, a dispute and recovery log, and a close package your auditors can follow.
FAQ
Questions
Who do you work with?
Pharma and biotech manufacturers, medtech manufacturers, and distributors. We work with the pricing, contracting, finance, market access, trade, and revenue-operations teams who own gross-to-net, rebates, chargebacks, program pricing, or the systems behind them.
What do you do for medtech manufacturers?
Contract pricing, GPO and IDN tiers, rebates, chargebacks, accruals, gross-to-net, and VA FSS. Government drug-pricing programs such as Medicaid, 340B, Part B ASP, and the IRA apply to drug and biologic manufacturers, not devices.
What do you do for distributors?
Contract-price loads, chargeback submission and reconciliation, GPO and IDN eligibility, and the EDI 844/849/867 flows between you and your manufacturers, so chargebacks get paid in full and on time.
Is delivery principal-led?
Yes. The senior practitioner who scopes the work does it. We keep few engagements running at once, so every transaction in scope is reviewed, not sampled.
What systems do you work in?
Whatever you already run: CRM, ERP, spreadsheets, or specialty revenue tools. We build and operate there, on any platform.
How do you handle confidentiality?
Client names, figures, and materials stay confidential. Engagement work proceeds under NDA when required.
What happens after I reach out?
We reply within one business day to set up a 30-minute call. If there's a fit, you get a written scope and a fixed fee for Assess.
What does a typical timeline look like?
Assess runs 2 weeks at a fixed scope and fixed fee. Builds depend on scope and your environment. Run engagements follow your close, monthly or quarterly.
Contact
Book a 30-minute call
Tell us what you're working on. We reply within one business day to set up a 30-minute call. If there's a fit, you get a written scope and a fixed fee for a 2-week Assess.